	Sex-specific association of visceral adiposity index with renal dysfunction in chinese type 2 diabetes: A cross-sectional study. PLoS One Liu S, Ma L, Niu Y, Ma R, Qi T, Shi B. PMID: 41739815 [PubMed - in process]
	Design and Reporting Quality of Noninferiority Trials in Kidney Transplantation: A Systematic Review. J Am Soc Nephrol Shi B, Bleasel JM, Ying T, Chadban SJ. PMID: 41739578 [PubMed - as supplied by publisher]
	Knowledge, Attitude, and Practice of Clinicians Regarding Continuous Renal Replacement Therapy for Critical Care Patients in Southern Palestine. Crit Care Nurs Q Awawdeh Y, Abu Ejheisheh M, Ayed A, Aqtam I, Batran A. PMID: 41739512 [PubMed - indexed for MEDLINE]
	SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer. JAMA Netw Open Udovicich C, Cheung P, Chu W, Chung H, Detsky J, Liu S, Morton G, Tseng CL, Vesprini D, Hudson JM, Ong WL, Kennedy T, Helou J, Davidson M, Ravi A, McGuffin M, Zhang L, Mamedov A, Deabreu A, Kulasingham-Poon M, Loblaw A. PMID: 41739470 [PubMed - indexed for MEDLINE]
	Obesogens in Prostate Cancer: An Endocrine and Metabolic Threat. Curr Obes Rep Feijó M, Fonseca LRS, Kiss-Toth E, Socorro S, Correia S. PMID: 41739363 [PubMed - in process]
	Sound therapy in renal disease management: a narrative review by the Kasr Al-Ainy Nephrology Group (KANG). Int Urol Nephrol Soliman AR, Elkhatib M, El-Khashab S, Abdelaziz TS, Hammad H, Ahmed RM, Maamoun HA, Dorgham A, Fayed A, Marzouk A. PMID: 41739358 [PubMed - as supplied by publisher]
	Zoledronic acid for chronic kidney disease-associated osteoporosis. Arch Osteoporos Sakthivel S, Kjærgaard KD, Ivarsen P, Langdahl B, Jørgensen HS. PMID: 41739309 [PubMed - indexed for MEDLINE]
	Real-world comparison of RezÅ«m(Â®) water vapor therapy and transurethral resection of the prostate using a pragmatic composite definition of procedural success. World J Urol Pina-Vaz T, Costa Silva A, Henriques M, Antunes H, Dias P, Martins-Silva C, Silva JA, Morgado A. PMID: 41739198 [PubMed - indexed for MEDLINE]
	Pattern of disease recurrence and outcomes after progression of high-risk renal cell carcinoma (RCC) patients treated with adjuvant immunotherapy. Cancer Immunol Immunother Ciccarese C, Occhipinti D, Arduini D, Di Leo D, Neri A, Roca L, Messina G, Troisi P, Pedone RR, Fucile MA, Belletto R, Sardaro V, Ligato C, Ajdhoni R, Caliciotti F, Sighinolfi C, Tagliaferri L, Rocco B, Tortora G, Iacovelli R. PMID: 41739194 [PubMed - indexed for MEDLINE]
	A real-world comparison of nivolumab plus cabozantinib and pembrolizumab plus lenvatinib focusing on safety outcomes in metastatic renal cell carcinoma: results from the JK-FOOT consortium. Cancer Immunol Immunother Yanagisawa T, Mori K, Kawada T, Katayama S, Tsujino T, Maenosono R, Toyoda S, Nukaya T, Morinaka H, Tamura K, Fukuokaya W, Urabe F, Murakami M, Bekku K, Takahara K, Fujita K, Azuma H, Araki M, Inamoto T, Komura K, Kimura T, JK-FOOT study group. PMID: 41739193 [PubMed - indexed for MEDLINE]
	[Genital dermatoses in clinical practice: Beyond sexually transmitted diseases]. Dermatologie (Heidelb) Kostner D, Possanner C, Strobl J. PMID: 41739154 [PubMed - as supplied by publisher]
	Family Matters: Dissecting the Impact of Family Medical History, APOL1 Genotype, and Sociodemographic Factors on CKD Progression in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis Fischman CJ, Zee J, Campbell KN. PMID: 41739029 [PubMed - as supplied by publisher]
	Evaluating the Safety and Performance of the KidneYou App for Chronic Kidney Disease: Protocol for an Italian Multicenter, Randomized, Open-Label, Premarket Study. JMIR Res Protoc Cafiero C, Gnesi M, Maurizi AR, Foresta A, Beccaria M, Campilongo G, Fiorentino M, Acquaviva PM, Mastromauro F, Gorini M, Gesualdo L. PMID: 41738544 [PubMed - indexed for MEDLINE]
	Bench-to-Bedside Evaluation of Sulforaphane/BroccoMaxÂ® on Fatty Acid Synthesis in Prostate Cancer. Cancer Prev Res (Phila) Hahm ER, Jacobs BL, Singh KB, Kim SH, Parikh R, Normolle DP, Dhir R, Oyebamiji T, Sun X, Liu Y, Appleman LJ, Gelhaus SL, Singh SV. PMID: 41738426 [PubMed - as supplied by publisher]
	Interleukin-17A and Thyroid Autoantibodies in Follicular Fluid and Their Relation to Ovarian Response. Am J Reprod Immunol Amr HM, Gaafar TM, El-Wakeel R, Sharaf MA, Hanna MOF. PMID: 41738353 [PubMed - indexed for MEDLINE]
	Emerging therapies to overcome antiandrogen resistance and beyond in lethal prostate cancer. J Natl Cancer Cent Huang F, Li K, Shevach JW, Wang Q. PMID: 41738039 [PubMed]
	Genetic and epigenetic mechanisms underlying treatment-induced neuroendocrine prostate cancer. J Natl Cancer Cent Keo V, Lu X, Zhao JC, Yu J. PMID: 41738035 [PubMed]
	Alterations in AR-FOXA1 signaling in prostate cancer progression and therapeutic resistance. J Natl Cancer Cent Gao S, Patten ND, Cai C. PMID: 41738032 [PubMed]
	Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer. J Natl Cancer Cent Shuai Y, Huang H. PMID: 41738031 [PubMed]
	Estimated Glomerular Filtration Rate Slope Predicts Survival and Renal Outcomes in Myeloperoxidase-Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis: Development and Validation of a Pathogen-Free Model. Kidney Dis (Basel) Wang J, Kong W, Wang J, Ni A, Huang X, Chen L, Wang M, Ma Y, Ren P, Chen J, Han F. PMID: 41737911 [PubMed]

Articles 1 - 20 / 466537

Page 1 of 23327



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy